Literature DB >> 22895286

Update in uveal melanoma.

J William Harbour1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22895286      PMCID： PMC4469072     

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

1.  Frequent mutation of BAP1 in metastasizing uveal melanomas.

Authors:  J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock
Journal:  Science       Date:  2010-11-04       Impact factor: 47.728

2.  Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.

Authors:  Solange Landreville; Olga A Agapova; Katie A Matatall; Zachary T Kneass; Michael D Onken; Ryan S Lee; Anne M Bowcock; J William Harbour
Journal:  Clin Cancer Res       Date:  2011-10-28       Impact factor: 12.531

3.  Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Devron H Char; James J Augsburger; Zelia M Correa; Eric Nudleman; Thomas M Aaberg; Michael M Altaweel; David S Bardenstein; Paul T Finger; Brenda L Gallie; George J Harocopos; Peter G Hovland; Hugh D McGowan; Tatyana Milman; Prithvi Mruthyunjaya; E Rand Simpson; Morton E Smith; David J Wilson; William J Wirostko; J William Harbour
Journal:  Ophthalmology       Date:  2012-04-21       Impact factor: 12.079
  3 in total
  3 in total

1.  Decitabine limits escape from MEK inhibition in uveal melanoma.

Authors:  Jessica Gonçalves; Michael F Emmons; Fernanda Faião-Flores; Andrew E Aplin; J William Harbour; Jonathan D Licht; Márcia R Wink; Keiran S M Smalley
Journal:  Pigment Cell Melanoma Res       Date:  2019-12-06       Impact factor: 4.693

2.  Tumour Expression of Histone Deacetylases in Uveal Melanoma.

Authors:  Louis Levinzon; Michele Madigan; Vuong Nguyen; Enisa Hasic; Max Conway; Svetlana Cherepanoff
Journal:  Ocul Oncol Pathol       Date:  2018-09-18

3.  Multiple evanescent white dot syndrome-like reaction associated with ipilimumab and nivolumab immune checkpoint inhibitor therapy for metastasis of choroidal melanoma.

Authors:  Ryan T Duong; Naveen R Ambati; Krishi V Peddada; Omar Elghawy; Elizabeth M Gaughan; Yevgeniy Shildkrot
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.